In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way drugeruptiondata.com uses cookies please read our 'Cookie Policy'.
Loading more results
No more results to show
Adverse reactions attributed to entire drug class 'Muscarinic antagonist'
Please login to view adverse reactions.
Cardiovascular adverse effect (includes major adverse cardiovascular events (MACE))
- (2019): Katoh T+, Low Urin Tract Symptoms Sep, Epub ahead of print≤ 6% (with mirabegron)
- (2019): Katoh T+, Low Urin Tract Symptoms Sep, Epub ahead of print (with mirabegron)
QT interval prolonged / QT prolongation
- (2019): Katoh T+, Low Urin Tract Symptoms Sep, Epub ahead of print (with mirabegron)
- (2019): Katoh T+, Low Urin Tract Symptoms Sep, Epub ahead of print (with mirabegron)
Adverse effects / adverse reactions
- (2021): Yang N+, J Int Med Res Sep, Online ahead of print [REVIEW]
